临床试验

Auricular Vagal Neuromodulation for Depression and Anxiety in Substance Use Disorder

NCT：NCT07814755 · NOT_YET_RECRUITING

NCT编号NCT07814755

状态NOT_YET_RECRUITING

SponsorDaisy Thompson-Lake (OTHER)

First posted2026-09-11

Last updated2026-09-11

简要摘要

This pilot study will evaluate whether home-based auricular vagal neuromodulation therapy (AVNT) is practical, acceptable, and well tolerated for adults receiving treatment for substance use disorder. Participants will use a handheld device that delivers mild electrical stimulation to the ear for approximately 60 minutes each day over 30 days. Researchers will examine whether participants can successfully use the device as directed and complete study procedures. The study will also explore whether use of the device is associated with changes in depression, anxiety, sleep problems, and substance craving.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。